Stay updated on ALD403 Safety Tolerability Pharmacokinetics in Clinical Trial

Sign up to get notified when there's something new on the ALD403 Safety Tolerability Pharmacokinetics in Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ALD403 Safety Tolerability Pharmacokinetics in Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    2 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.8.0 to v2.8.1, indicating a recent revision in the content of the webpage.
    Difference
    0.1%
    Check dated 2024-06-13T21:31:23.000Z thumbnail image
  4. Check
    4 days ago
    No Change Detected
  5. Check
    5 days ago
    No Change Detected
  6. Check
    10 days ago
    Change Detected
    Summary
    The value 7 has recently changed to 8 on the webpage, indicating a modification in the study completion date from 2012-12 to 2013-04 for the safety, tolerability, and pharmacokinetics study of ALD403, a monoclonal antibody used in the treatment of migraine disorders.
    Difference
    0.1%
    Check dated 2024-06-06T14:31:08.000Z thumbnail image
  7. Check
    25 days ago
    Change Detected
    Summary
    The webpage has updated the 'Participation Criteria' section to provide detailed eligibility criteria for study participants, including specific health conditions and prior treatments required for inclusion. This change likely pertains to medical and healthcare-related documentation, particularly in the context of clinical research studies.
    Difference
    40%
    Check dated 2024-05-22T21:09:55.000Z thumbnail image
  8. Check
    46 days ago
    Change Detected
    Difference
    1%
    Check dated 2024-04-30T23:11:28.000Z thumbnail image

Stay in the know with updates to ALD403 Safety Tolerability Pharmacokinetics in Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ALD403 Safety Tolerability Pharmacokinetics in Clinical Trial page.